# Cytokine Profiling of Exudates from Periapical Lesions and the Efficacy of CXCL10 as a Healing Marker

**Authors:** Kazuhisa Ouhara, Yuri Taniguchi, Ruoqi Zhai, Katsuhiro Takeda, Ryousuke Fujimori, Naoya Kuwahara, Shoya Ueda, Yitong Hou, Nomi Honoka, Masaru Shimizu, Shoko Kono, Tomoyuki Iwata, Shinji Matsuda, Noriyoshi Mizuno

PMC · DOI: 10.3390/pathogens14101013 · Pathogens · 2025-10-07

## TL;DR

This study analyzed cytokine levels in periapical lesions and found that higher CXCL10 levels correlate with better healing outcomes.

## Contribution

The study identifies CXCL10 as a potential healing marker for periapical lesions.

## Key findings

- CXCL10 levels were elevated in patients with favorable healing of periapical lesions.
- Cytokine profiles varied significantly across patient samples before and after treatment.
- CXCL10 improved BMMC migration in vitro, supporting its role in healing.

## Abstract

This study aimed to evaluate cytokine profiling in a periapical lesion to provide a rationale for future treatment strategies for periapical lesions. Thirteen samples of exudative fluid were collected from such a lesion directly through the root canal. Cytokine profiling was performed using the Bio-Plex system. CXCL10 (C-X-C motif chemokine ligand 10, IP10) was found to be elevated in apical exudates of patients exhibiting favorable healing. To evaluate the role of CXCL10 in cell migration, a Transwell assay was conducted using bone marrow-derived mononuclear cells (BMMCs). Different types of cytokines were detected from the samples of periapical lesion at the initial visit. However, cytokine production varied across patient samples. Release of interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, IL-17, granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon gamma (IFN-γ), monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1α, MIP-1β, and tumor necrosis factor (TNF)-α showed differential expression. Comparison of cytokine profiles indicated that cytokine production was variable before and after root canal treatment. In vitro, CXCL10 significantly improved BMMC migration in a dose-dependent manner, supporting clinical findings that elevated CXCL10 levels are associated with favorable healing in apical lesions. Although this study was limited by the small sample size and exploratory design, the cytokine profile of periapical lesions may be useful for assessing the condition of periapical lesions and modulating the immune response to bacterial infection.

## Linked entities

- **Genes:** CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627]
- **Proteins:** IL1B (interleukin 1 beta), IL2 (interleukin 2), IL4 (interleukin 4), IL5 (interleukin 5), IL6 (interleukin 6), CXCL8 (C-X-C motif chemokine ligand 8), IL10 (interleukin 10), IL12 (Interleukin 12 level), IL13 (interleukin 13), IL17A (interleukin 17A), CSF3 (colony stimulating factor 3), CSF2 (colony stimulating factor 2), IFNG (interferon gamma), CCL2 (C-C motif chemokine ligand 2), CCL3 (C-C motif chemokine ligand 3), CCL4 (C-C motif chemokine ligand 4), TNF (tumor necrosis factor)

## Full-text entities

- **Genes:** IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, CSF3 (colony stimulating factor 3) [NCBI Gene 1440] {aka C17orf33, CSF3OS, GCSF}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL5 (interleukin 5) [NCBI Gene 3567] {aka EDF, IL-5, TRF}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}
- **Diseases:** Periapical Lesions (MESH:D010483), bacterial infection (MESH:D001424)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12567456/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12567456/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12567456/full.md

---
Source: https://tomesphere.com/paper/PMC12567456